[Clinical effects of cerebral revascularization combined with isovolemic hemodilution in acute stage of ischemic stroke].
نویسندگان
چکیده
Superficial temporal artery-middle cerebral artery (STA-MCA) bypass is widely accepted as an effective treatment for ischemic cerebrovascular disease in terms of improvement of cerebral blood flow in the ischemic region. However, the indications for and timing of STA-MCA bypass in the acute stage of ischemic stroke have not been established. Isovolemic hemodilution has been shown to temporarily raise collateral perfusion in acutely ischemic brain regions distal to occluded cerebral arteries. The authors performed isovolemic hemodilution in 26 cases of cerebral ischemia within 72 hours of the onset of symptoms. This resulted in a 30% increase in regional cerebral blood flow (rCBF) in the area supplied by the affected MCA, leading to rapid neurological improvement in 18 patients. Nine of these 18 were randomly assigned to the early bypass group, in which STA MCA bypass was performed within 2 days of hemodilution. In the delayed bypass group, which in cluded the remaining nine patients, bypass was performed more than 30 days after hemodilution. In the early group, rCBF in the affected MCA region increased by 18% and the neurological score (NS) improved by 10% within 1 month postoperatively. In the delayed group, follow-up examina tion 1 to 2 months after hemodilution, rCBF in the affected MCA region and NS had returned nearly to pretreatment levels. Moreover, in this group STA-MCA bypass improved neither rCBF nor neurological status. It can be concluded that isovolemic hemodilution temporarily increases rCBF in the ischemic territory and enhances the potential reversibility of neuronal damage in patients with acute ischemic stroke. Neuronal damage may be reversed and rCBF may be signifi cantly improved if blood flow is re-established by surgical means (STA-MCA bypass) within hours or days following hemodilution.
منابع مشابه
Acute effects of isovolemic hemodilution with crystalloids in a canine model of focal cerebral ischemia.
We used 44 splenectomized dogs to study the effects of isovolemic hemodilution with a crystalloid solution. The dogs were randomly divided into a hemodilution and a control group. In each group, 17 dogs were subjected to 6 hours of internal carotid and middle cerebral artery occlusion, and five dogs received sham operations. Isovolemic hemodilution by phlebotomy and Ringer's lactate infusion wa...
متن کاملModification of focal cerebral ischemia by cardiac output augmentation.
Intravascular volume expansion has been employed successfully for treatment of ischemic stroke from cerebral vasospasm and from cerebrovascular occlusive disease. The physiologic mechanism responsible for this success has not previously been delineated in controlled experimentation. The objective of this investigation was to delineate the effects of cardiac output and of hemodilution in a prima...
متن کاملNeurological deterioration under isovolemic hemodilution with hydroxyethyl starch in acute cerebral ischemia.
In a prospective study, we randomly allocated 70 patients with acute ischemic stroke to two therapy groups. Up to interim analysis, 33 patients underwent bloodletting, with simultaneous infusion of an identical volume of hydroxyethyl starch (10%, 200/0.5). The target hematocrit was 35%. A control group of 37 patients did not receive hemodilution. Apart from an unequal sex distribution, the two ...
متن کاملThe Effect of Intravenous Magnesium Sulfate in Improvement of Acute Ischemic Stroke Induced Disability: A Randomized Double Blinded Clinical Trial
Background: Stroke is the third main cause of death and chronic disabilities in adults, which requires finding neuroprotective drugs to reduce its mortality and morbidity. Objectives: To determine the efficacy of magnesium sulfate as an adjunctive neuroprotective agent in patients with stroke. Materials & Methods: This randomized double-blind clinical trial recruited 120 patients with acute ...
متن کاملIntravenous Thrombolysis for Acute Ischemic Stroke due to Cardiac Myxoma; A Case Report
Myxoma may cause systemic embolization and frequently presents as ischemic stroke. There has been debates whether it is safe to use recombinant tissue plasminogen activator (rt-PA) in patients with cardiac myxoma who are presented with ischemic stroke at emergency department. we describe a young case of atrial myxoma with initial presentation of acute cerebral infarction symptoms who was treate...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Neurologia medico-chirurgica
دوره 28 8 شماره
صفحات -
تاریخ انتشار 1988